company

VALDRES BIOVARME AS

2900 FAGERNES

Return on Equity
19,02 %
Current Ratio
1,11
Debt-to-Equity Ratio
2,51
Key figures (NOK)2022
Revenue6 191 000
Net Income1 325 000
Total Assets26 314 000
Total Equity6 966 000
Income (NOK)2022
Revenue6 191 000
Expenditure3 728 000
Operating Profit2 463 000
Financial Income7 000
Financial Costs771 000
Financial Balance−764 000
Earnings Before Tax1 699 000
Tax374 000
Net Income1 325 000
Balance (NOK)2022
Total Fixed Assets24 266 000
Total Current Assets2 048 000
Total Assets26 314 000
Total Retained Equity4 196 000
Total Equity6 966 000
Total Long-Term Debt17 498 000
Total Current Debt1 849 000
Total Equity and Debt26 314 000
Cash flow (NOK)2022
Sales Income6 191 000
Other Income0
Revenue6 191 000
Cost of Goods Sold1 650 000
Salary Costs417 000
Depreciation812 000
Impairment0
Expenditure3 728 000
Operating Profit2 463 000
Financial Income7 000
Financial Costs771 000
Financial Balance−764 000
Dividends0
Net Income1 325 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate24 215 000
Machinery and Plant Facilities51 000
Fixtures0
Total Tangible Assets24 266 000
Total Fiancial Fixed Assets0
Total Fixed Assets24 266 000
Stock796 000
Total Investments0
Cash, Bank17 000
Total Current Assets2 048 000
Total Assets26 314 000
Total Equity6 966 000
Short-Term Group Debt0
Total Long-Term Debt17 498 000
Creditors1 359 000
Unpaid Taxes53 000
Dividends0
Other Current Debt438 000
Total Current Debt1 849 000
Total Equity and Debt26 314 000
Financial indicators2022
Return on Equity19,02 %
Debt-to-Equity Ratio2,51
Operating Profit Margin39,78 %
Current Ratio1,11
Quick Ratio1,94
Equity Ratio0,26
Gross Profit Margin73,35 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English